The nervous system medicine sales in Japan show a steady growth from 2024 to 2028, starting at 79.9 USD PPP per capita in 2024 and reaching 85.2 USD PPP per capita in 2028. This reflects a consistent year-on-year increase, with the market expanding each subsequent year. Although the exact percentage changes are not provided, the data suggests a strong, upward trend.
Future trends to watch for include:
- The impact of Japan's aging population on the demand for nervous system medications.
- Advancements in medical technology and how they might influence treatment options and market expansion.
- Potential shifts in regulatory policies that could affect pharmaceutical sales.
